首页> 外文期刊>Peptides: An International Journal >Analysis of responses to hAmylin, hCGRP, and hADM in isolated resistance arteries from the mesenteric vascular bed of the rat.
【24h】

Analysis of responses to hAmylin, hCGRP, and hADM in isolated resistance arteries from the mesenteric vascular bed of the rat.

机译:分析大鼠肠系膜血管床中分离的阻力动脉中对hAmylin,hCGRP和hADM的反应。

获取原文
获取原文并翻译 | 示例
       

摘要

Responses to human calcitonin gene-related peptide (hCGRP) and human adrenomedullin (hADM) hAmylin were investigated in isolated mesenteric resistance arteries from the rat. The results of the present investigation show that hCGRP, hAmylin, and hADM induce dose-related vasodilator responses in isolated resistance arteries from the rat mesenteric vascular bed. Vasodilator responses to hCGRP and hAmylin were not altered after denuding the vascular endothelium, after administration of the nitric oxide synthase inhibitor L-NA, or after administration of the soluble guanylate cyclase inhibitor ODQ, suggesting that vasodilator responses to hCGRP and hAmylin are not mediated by the release of nitric oxide from the vascular endothelium and the subsequent increase in cGMP. Vasodilator responses to hCGRP, hAmylin, and hADM were not altered by the vascular selective K(+)(ATP) channel antagonist U-37883A. The role of the CGRP(1) receptor was investigated and responses to hCGRP and hAmylin, but not hADM, were significantly reduced following administration of hCGRP-(8-37). Moreover, vasodilator responses to hCGRP and hAmylin, but not hADM, were significantly reduced by hAmylin-(8-37), suggesting that an hAmylin-(8-37)-sensitive receptor mediates responses to hCGRP and hAmylin in the rat mesenteric artery. These data suggest that hCGRP and hAmylin have direct vasodilator effects in the isolated mesenteric resistance artery that are mediated by hAmylin-(8-37)- and hCGRP-(8-37)-sensitive receptors.
机译:在从大鼠分离的肠系膜抗性动脉中研究了对人降钙素基因相关肽(hCGRP)和人肾上腺髓质素(hADM)hAmylin的反应。本研究的结果表明,hCGRP,hAmylin和hADM在大鼠肠系膜血管床分离的阻力动脉中诱导了剂量相关的血管舒张反应。剥除血管内皮后,给予一氧化氮合酶抑制剂L-NA或给予可溶性鸟苷酸环化酶抑制剂ODQ后,对hCGRP和hAmylin的血管舒张反应没有改变,这表明对hCGRP和hAmylin的舒张血管反应没有被介导。一氧化氮从血管内皮中的释放以及随后cGMP的增加。血管选择性K(+)(ATP)通道拮抗剂U-37883A不会改变对hCGRP,hAmylin和hADM的血管舒张反应。研究了CGRP(1)受体的作用,并在施用hCGRP-(8-37)后显着降低了对hCGRP和hAmylin(而非hADM)的反应。此外,hAmylin-(8-37)显着降低了对hCGRP和hAmylin而非hADM的血管舒张反应,这表明hAmylin-(8-37)敏感受体介导了大鼠肠系膜动脉对hCGRP和hAmylin的反应。这些数据表明,hCGRP和hAmylin在由hAmylin-(8-37)-和hCGRP-(8-37)-敏感受体介导的分离的肠系膜阻力动脉中具有直接的血管舒张作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号